Patients, caregivers, family members and advocates have a critical role to play in high-quality medication use. They provide unique and valuable insights about what is important and meaningful in medication use quality, which supports the development of appropriate and useful quality measures, as well as related education, research and tools that support informed health care decisions and better medication use outcomes.
PQA mourns the passing of CMS Chief Medical Officer Jeffrey Kelman, MD, MMSc. Kelman served on the PQA Board of Directors for 10 years and most recently served on the board as a CMS Special Advisor. Kelman was a trusted advisor to PQA since its establishment in 2006. He was kind, generous and thoughtful in his support of PQA and its mission.
Kelman joined CMS in 2005 and helped implement the Part D program. He was a passionate advocate for patient-centered care and efforts to improve the quality of medication use. On behalf of our board, members and staff, PQA sends condolences to his family, friends, colleagues and the countless lives he touched during his life and career.
See Dr. Kelman's obituary for more on his life, accomplishments and family.
There is tremendous momentum and a keen focus among PQA member organizations on addressing social determinants and social drivers of health (SDOH). SDOH impacts every aspect of care, including medication use, and the impact of unmet health-related social needs on patient access and use of care, outcomes, total cost of care, well-being and satisfaction is apparent and a priority to payers and providers.
To build a larger and more diverse quality workforce, the PQA Quality Shadowing Program provides individuals from diverse groups the opportunity to observe certain nomination-based panels to gain knowledge that can support selection for future panels.
PQA has published more than 80 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2023, here’s a look back at the top five blogs of the year.
As we near the end of 2023, it’s a great time to reflect on our accomplishments this year. Certainly, each year brings its share of opportunities and challenges, and I’m proud of our progress as an alliance.
At PQA, you may have noticed that we appreciate sports analogies. Earlier this summer, PQA CEO Micah Cost discussed what baseball and quality measures have in common. In keeping with the baseball theme, PQA is entering the top of the 7th for 2023, and there is still plenty of time for members to get in the game.
The 2023 PQA Annual Meeting poster session featured 24 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, the session provided an opportunity for authors to showcase their work and for attendees to engage in insightful dialogue about health care quality.
PQA has a new look! Our fresh and modernized logo and color scheme reflect our positive, forward-looking view of the vital role of medications in health care – and our role in bringing the industry together to improve quality.
The 2023 PQA Annual Meeting is May 10-12 in Nashville, Tenn. You’ll hear from more than 50 speakers across our general, breakout and special sessions.
Let PQA be part of the strategy to ensure your staff has robust and in-person opportunities for networking, professional development, continuing education, and strategic engagement with business partners and prospects.
The 2023 PQA Annual Meeting, May 10-12 in Nashville, Tenn., is one of most affordable and accessible national meetings:
The 2023 PQA Annual Meeting poster session will feature 25 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, the session provides an opportunity for authors to showcase their work and for attendees to engage in insightful dialogue about health care quality.
PQA will bring its members and industry experts together on November 2 to discuss the state of medication therapy management (MTM) practice, implications of recent Centers for Medicare & Medicaid Services proposals and opportunities to evolve MTM quality measurement.
Shadowing programs are a great way to gain knowledge and insights about technical programs and processes.
The Pharmacy Quality Alliance (PQA) is providing scholarships for minority health care professional students to attend the 2023 PQA Annual Meeting, May 10-12, in Nashville, Tenn., and participate in the pre-meeting Medication Use Quality (MUQ) Live workshop on May 10. This scholarship opportunity is part of the PQA Diverse Quality Leaders Program.
In the year ahead, PQA will continue developing innovative measure approaches for high-impact areas of care. From technical expert panels, stakeholder advisory meetings, the measure endorsement vote and convening events focused on future measure opportunities, PQA members have the opportunity to be involved each step of the way!
PQA’s education team has a lot on deck for 2023, focused on the latest in best practices and innovative approaches to improve quality medication use. PQA started the year by publishing the second edition of the PQA Social Determinants of Health (SDOH) Resource Guide and will continue education offerings through quality forum webinars, highlighting PQA members during the 2023 PQA Annual Meeting and the much-anticipated relaunch of the PQA Medication Use Quality certificate program.
PQA’s 2023 calendar is full of opportunities to engage in our work and advance the quality of medication use. PQA meetings and convening events are just one example of how members can engage with the wide array of health care stakeholders from across our membership.
It’s a new year and there are several big things on the horizon to keep an eye on in pharmacy, medication use and high-quality, value-based care.
PQA’s 2023 calendar is shaping up to be full of opportunities for members to engage in our work and advance the quality of medication use. PQA is building on the momentum we gained in 2022, and there will be many opportunities to engage in our:
